Method for inducing tumor cells to form tumor stem cells
A tumor stem cell and tumor cell technology, applied in the field of inducing tumor cell lines to form tumor stem cells, to achieve the effects of improving adaptability, breaking the limitation of consumables, and reducing adhesion ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] This embodiment provides a method for inducing tumor cells to form tumor stem cells, specifically using HepG2 (human liver cancer cells) as experimental cells, including the following steps:
[0035] (1) Prepare tumor stem cell induction medium: add 2% B27 cell supplement and 1% P / S (penicillin-streptomycin mixture) to DMEM / F12 medium at a concentration of 20 ng / mL RecombinantHuman LIF (human leukemia inhibitory factor), 20ng / mL of Recombinant Human FGFb (human basic fibroblast growth factor) and 20ng / mL of Recombinant Human EGF (human epidermal growth factor).
[0036] (2) Take tumor cells in good growth state in the logarithmic growth phase.
[0037] (3) Inoculation: After preparing the experimental materials, the tumor cells in the logarithmic growth phase were inoculated into the cell culture dish.
[0038] (4) Serum-free synchronization: After the cells enter the logarithmic growth phase, add serum-free DMEM / F12 medium and perform synchronization for 12 hours.
...
Embodiment 2
[0044] This embodiment provides a method for inducing tumor cells to form tumor stem cells, specifically using HCCLM3 (human highly metastatic liver cancer cells) as experimental cells, including the following steps:
[0045] (1) Prepare tumor stem cell induction medium: add 2% B27 cell supplement and 1% P / S (penicillin-streptomycin mixture) to DMEM / F12 medium at a concentration of 20 ng / mL RecombinantHuman LIF (human leukemia inhibitory factor), 20ng / mL of Recombinant Human FGFb (human basic fibroblast growth factor) and 20ng / mL of Recombinant Human EGF (human epidermal growth factor).
[0046] (2) Take tumor cells in good growth state in the logarithmic growth phase.
[0047] (3) Inoculation: After preparing the experimental materials, the tumor cells in the logarithmic growth phase were inoculated into the cell culture dish.
[0048] (4) Serum-free synchronization: After the cells enter the logarithmic growth phase, add serum-free DMEM / F12 medium and perform synchronizatio...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com